We are live on ! Find out more
T. Rowe Price Associates

T. Rowe Price Associates Portfolio holdings

AUM $865B
1-Year Est. Return 30.76%
 

T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.

This Fund
S&P 500
This Quarter Est. Return
+5.57%
1 Year Est. Return
+30.76%
3 Year Est. Return
+117.39%
5 Year Est. Return
+143.85%
10 Year Est. Return
+1,089.89%
AUM
$999B
AUM Growth
+$24.7B
Cap. Flow
-$14B
Cap. Flow %
-1.41%
Top 10 Hldgs %
24.27%
Holding
2,908
New
248
Increased
1,171
Reduced
1,334
Closed
66

Top Buys

Rank Stock Value
1
ZM icon
Zoom
ZM
+$3.3B
2
LLY icon
Eli Lilly
LLY
+$2.75B
3
AZN icon
AstraZeneca
AZN
+$1.98B
4
CPNG icon
Coupang
CPNG
+$1.54B
5
FTNT icon
Fortinet
FTNT
+$1.48B

Top Sells

Rank Stock Value
1
NXPI icon
NXP Semiconductors
NXPI
+$2.34B
2
MS icon
Morgan Stanley
MS
+$2.26B
3
ABNB icon
Airbnb
ABNB
+$2.04B
4
QCOM icon
Qualcomm
QCOM
+$1.95B
5
NVDA icon
NVIDIA
NVDA
+$1.81B

Sector Composition

Rank Sector Weight
1 Technology 23.35%
2 Healthcare 16.19%
3 Consumer Discretionary 15.55%
4 Financials 12.84%
5 Communication Services 12.27%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
EMWP
2826
DELISTED
Eros Media World PLC
EMWP
$20K ﹤0.01%
+555
New +$22.3K
CTXR icon
2827
Citius Pharmaceuticals
CTXR
$21.1M
$19K ﹤0.01%
416
EUCRW
2828
DELISTED
Eucrates Biomedical Acquisition Corp. Warrant
EUCRW
$14K ﹤0.01%
+15,931
New +$25.8K
ACWI icon
2829
iShares MSCI ACWI ETF
ACWI
$33.6B
-468,100
Closed -$42.5M
ANGL icon
2830
VanEck Fallen Angel High Yield Bond ETF
ANGL
$3.11B
-304,600
Closed -$9.78M
APRE icon
2831
Aprea Therapeutics
APRE
$8.13M
-1,494
Closed -$147K
APVO icon
2832
Aptevo Therapeutics
APVO
$5.34M
0
-$231K
BCAB icon
2833
BioAtla
BCAB
$5.46M
-12,770
Closed -$21.7M
CRDF icon
2834
Cardiff Oncology
CRDF
$79.4M
-529,627
Closed -$9.53M
CRMT icon
2835
America's Car Mart
CRMT
$26.9M
-2,126
Closed -$234K
CULP icon
2836
Culp Inc
CULP
$43.9M
-347,528
Closed -$5.51M
CWEN.A
2837
DELISTED
Clearway Energy Class A
CWEN.A
-15,137
Closed -$447K
DESP
2838
DELISTED
Despegar.com
DESP
-139,700
Closed -$1.79M
DYN icon
2839
Dyne Therapeutics
DYN
$4.89B
-484,952
Closed -$10.2M
FLUX icon
2840
Flux Power
FLUX
$12.4M
-11,400
Closed -$197K
HYG icon
2841
iShares iBoxx $ High Yield Corporate Bond ETF
HYG
$17.9B
-138,000
Closed -$12M
IDT icon
2842
IDT Corp
IDT
$1.64B
-10,745
Closed -$133K
IESC icon
2843
IES Holdings
IESC
$14.9B
-4,578
Closed -$211K
III icon
2844
Information Services Group
III
$249M
-20,343
Closed -$67K
IWD icon
2845
CALL
iShares Russell 1000 Value ETF
IWD
$84.2B
-663,500
Closed -$90.7M
JNK icon
2846
State Street SPDR Bloomberg High Yield Bond ETF
JNK
$7.33B
-108,000
Closed -$11.8M
LE icon
2847
Lands' End
LE
$398M
-12,797
Closed -$276K
LEN.B icon
2848
Lennar Class B
LEN.B
$20.5B
-6,022
Closed -$350K
METC icon
2849
Ramaco Resources Class A
METC
$674M
-11,318
Closed -$32K
MUX icon
2850
McEwen Inc
MUX
$1.14B
-25,970
Closed -$256K

Similar funds

T. Rowe Price Associates's Q1 2021 Portfolio in Review

As of Q1 2021, T. Rowe Price Associates held 2,908 positions worth $999B, up 2.5% from $974B the previous quarter. Its ten largest holdings account for 24% of the portfolio.

T. Rowe Price Associates's Q1 2021 filing shows 248 new, 1,171 increased, 1,334 reduced and 66 closed positions. Its largest new stake was Coupang: 33,380,859 shares worth $1.63B. The largest sale was NXP Semiconductors, an estimated $2.34B.

By sector, the portfolio is most concentrated in Technology at 23% of assets, down from 25% a quarter earlier, followed by Healthcare and Consumer Discretionary.

  • T. Rowe Price Associates's largest Q1 2021 buy was Coupang: 33,380,859 shares worth $1.63B.
  • T. Rowe Price Associates added most to Zoom in Q1 2021, an estimated $3.3B increase.
  • T. Rowe Price Associates's biggest Q1 2021 reduction was NXP Semiconductors, cutting an estimated $2.34B.
  • T. Rowe Price Associates fully exited CONCHO RESOURCES INC. in Q1 2021, selling an estimated $205M.
  • T. Rowe Price Associates's ten largest holdings make up 24% of its $999B portfolio in Q1 2021.
  • T. Rowe Price Associates opened 248 new positions and closed 66 in Q1 2021.
  • T. Rowe Price Associates's portfolio value rose 2.5% quarter-over-quarter to $999B.

Based on T. Rowe Price Associates's 13F filing for Q1 2021, filed 17 May 2021.